Cardinal Health Inc (CAH)vsEDAP TMS SA (EDAP)
CAH
Cardinal Health Inc
$201.77
+1.22%
HEALTHCARE · Cap: $52.43B
EDAP
EDAP TMS SA
$4.31
+0.23%
HEALTHCARE · Cap: $156.30M
Smart Verdict
WallStSmart Research — data-driven comparison
Cardinal Health Inc generates 338402% more annual revenue ($250.74B vs $74.07M). CAH leads profitability with a 0.6% profit margin vs -41.7%. CAH appears more attractively valued with a PEG of 1.39. CAH earns a higher WallStSmart Score of 47/100 (D+).
CAH
Hold47
out of 100
Grade: D+
EDAP
Avoid25
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-31.2%
Fair Value
$170.63
Current Price
$201.77
$31.14 premium
Margin of Safety
+41.7%
Fair Value
$8.41
Current Price
$4.31
$4.10 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Large-cap with strong market position
Generating 1.7B in free cash flow
No standout strengths identified
Areas to Watch
Premium valuation, high expectations priced in
ROE of 0.0% — below average capital efficiency
0.6% margin — thin
Operating margin of 1.4%
Trading at 8.3x book value
Smaller company, higher risk/reward
Expensive relative to growth rate
ROE of -124.0% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : CAH
The strongest argument for CAH centers on Debt/Equity, Altman Z-Score, Market Cap. Revenue growth of 11.0% demonstrates continued momentum. PEG of 1.39 suggests the stock is reasonably priced for its growth.
Bull Case : EDAP
Revenue growth of 13.9% demonstrates continued momentum.
Bear Case : CAH
The primary concerns for CAH are P/E Ratio, Return on Equity, Profit Margin. Thin 0.6% margins leave little buffer for downturns.
Bear Case : EDAP
The primary concerns for EDAP are Price/Book, Market Cap, PEG Ratio.
Key Dynamics to Monitor
CAH profiles as a value stock while EDAP is a turnaround play — different risk/reward profiles.
CAH carries more volatility with a beta of 0.53 — expect wider price swings.
EDAP is growing revenue faster at 13.9% — sustainability is the question.
CAH generates stronger free cash flow (1.7B), providing more financial flexibility.
Bottom Line
CAH scores higher overall (47/100 vs 25/100) and 11.0% revenue growth. EDAP offers better value entry with a 41.7% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cardinal Health Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Cardinal Health, Inc. is an American multinational health care services company.
Visit Website →EDAP TMS SA
HEALTHCARE · MEDICAL DISTRIBUTION · USA
EDAP TMS SA, develops, produces, markets, distributes and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States and internationally. The company is headquartered in Lyon, France.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?